Krystal Biotech Inc KRYS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 12/09/22 EST
71.03UNCH (UNCH)
Volume
7,074
Close
71.03quote price arrow down-3.37 (-4.53%)
Volume
89,569
52 week range
47.67 - 85.11
Loading...
  • Open74.19
  • Day High74.19
  • Day Low70.97
  • Prev Close74.40
  • 52 Week High85.11
  • 52 Week High Date08/08/22
  • 52 Week Low47.67
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.829B
  • Shares Out25.75M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change1.54

KEY STATS

  • Open74.19
  • Day High74.19
  • Day Low70.97
  • Prev Close74.40
  • 52 Week High85.11
  • 52 Week High Date08/08/22
  • 52 Week Low47.67
  • 52 Week Low Date05/12/22
  • Market Cap1.829B
  • Shares Out25.75M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta0.86
  • YTD % Change1.54

RATIOS/PROFITABILITY

  • EPS (TTM)-5.20
  • P/E (TTM)-13.66
  • Fwd P/E (NTM)-15.08
  • EBITDA (TTM)-105.277M
  • ROE (TTM)-27.34%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Krystal Biotech Inc

 

Profile

MORE
Krystal Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of redosable gene therapies for patients living with debilitating diseases. It has developed a gene delivery platform that enables off-the-shelf treatments for serious dermatology and respiratory diseases. Its platform consists of an engineered viral vector derived from the herpes simplex virus type 1 (HSV-1) that it has optimized for local and repeat gene transfer to...
Krish Krishnan
Chairman of the Board, President, Chief Executive Officer
Kathryn Romano CPA
Chief Accounting Officer
Address
2100 Wharton St Ste 701
Pittsburgh, PA
15203-1973
United States

To